Clincosm LogoSign in Get a demo

Hepatocellular Carcinoma

Showing NaN - NaN of 176
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial in Worldwide (Ramucirumab, Placebo)

Completed
Has Results
  • Hepatocellular Carcinoma
  • Daly City, California
  • +130 more
Jan 5, 2022

CT Perfusion Parameters Predict Vascular Pattern in

Recruiting
  • Hepatocellular Carcinoma
  • CT perfusion examination
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
Dec 28, 2021

Hepatocellular Carcinoma Trial in Guangzhou (Apatinib, Camrelizumab, NK cell)

Recruiting
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    Nanfang Hospital of Southern Medical University
Dec 26, 2021

Hepatocellular Carcinoma Trial in Guangzhou (Donafenib+sintilimab)

Recruiting
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Dec 4, 2021

Hepatocellular Carcinoma Trial in Guangzhou (HAIC, Sorafenib)

Completed
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
Nov 16, 2021

Hepatocellular Carcinoma, Unresectable Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial in China (Lenvatinib,

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Hefei, Anhui, China
  • +9 more
Oct 21, 2021

Hepatocellular Carcinoma Trial in Guangzhou (Sintilimab; Bevacizumab Biosimilar)

Recruiting
  • Hepatocellular Carcinoma
  • Sintilimab; Bevacizumab Biosimilar
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 25, 2021

Hepatocellular Carcinoma, Transarterial Chemoembolization Trial in Guangzhou (TACE-HAIC plus lenvatinib)

Recruiting
  • Hepatocellular Carcinoma
  • Transarterial Chemoembolization
  • TACE-HAIC plus lenvatinib
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 20, 2021

Potentially Resection, Hepatocellular Carcinoma Trial in Guangzhou (TACE-HAIC, HAIC)

Recruiting
  • Potentially Resection
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 20, 2021

Hepatocellular Carcinoma Trial in Guangzhou (PD-1 inhibitor)

Recruiting
  • Hepatocellular Carcinoma
  • PD-1 inhibitor
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 20, 2021

Hepatocellular Carcinoma Trial in Guangzhou (Camrelizumab; Apatinib)

Recruiting
  • Hepatocellular Carcinoma
  • Camrelizumab; Apatinib
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 30, 2021

Hepatocellular Carcinoma Trial in Guangzhou (Hepatic arterial infusion chemo, Lenvatinib, Camrelizumab)

Recruiting
  • Hepatocellular Carcinoma
  • Hepatic arterial infusion chemotherapy
  • +2 more
  • Guangzhou, Guangdong, China
    Nanfang Hospital of Southern Medical University
Aug 5, 2021

Hepatocellular Carcinoma Trial in Guangzhou (Hepatic Arterial Infusion Chemotherapy (HAIC) Combine Lenvatinib and Durvalumab

Recruiting
  • Hepatocellular Carcinoma
  • Hepatic Arterial Infusion Chemotherapy (HAIC) Combine Lenvatinib and Durvalumab (HILL)
  • Guangzhou, Guangdong, China
    SUN YAT-SEN University Cancer Center
Jul 13, 2021

Lung Cancer, Hepatocellular Carcinoma, Solid Tumor Trial in Guangzhou (CpG-ODN)

Recruiting
  • Lung Cancer
  • +2 more
  • CpG-ODN
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Jun 27, 2021

Hepatocellular Carcinoma Trial in Guangzhou (Regorafenib Pill&Camrelizumab)

Recruiting
  • Hepatocellular Carcinoma
  • Regorafenib Pill&Camrelizumab
  • Guangzhou, Guangdong, China
    NanFang Hospital of Southern Medical University
Jun 28, 2021

Hepatocellular Carcinoma Trial in Guangzhou (PD-1 inhibitor)

Recruiting
  • Hepatocellular Carcinoma
  • PD-1 inhibitor
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Apr 21, 2021

Hepatocellular Carcinoma, Solid Tumor, Adult Trial in Guangzhou (Injection of drug-eluting microspheres into malignant tumors)

Recruiting
  • Hepatocellular Carcinoma
  • Solid Tumor, Adult
  • Injection of drug-eluting microspheres into malignant tumors
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Apr 6, 2021

Solid Tumor, Adult, Hepatocellular Carcinoma Trial in Guangzhou (Combination of three inhibitors Trametinib, Everolimus and

Recruiting
  • Solid Tumor, Adult
  • Hepatocellular Carcinoma
  • Combination of three inhibitors Trametinib, Everolimus and Lenvatinib
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Apr 7, 2021

Surgical Therapy and Survival in HCC/ C.F. Zhang et al.

Completed
  • Hepatocellular Carcinoma
  • Surgery
    • Guangzhou, Guangdong, China
      linzhu Zhai
    Mar 27, 2021

    Hepatocellular Carcinoma Trial in Guangzhou (stereotactic body radiotherapy, Sintilimab)

    Recruiting
    • Hepatocellular Carcinoma
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Mar 21, 2021

    Hepatocellular Carcinoma Trial in Guangzhou (neo-TACE-HAIC+Surgery, Surgery alone)

    Recruiting
    • Hepatocellular Carcinoma
    • neo-TACE-HAIC+Surgery
    • Surgery alone
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Feb 28, 2021

    Hepatocellular Carcinoma Trial in Guangzhou (Systemic chemo, Lenvatinib, Toripalimab)

    Recruiting
    • Hepatocellular Carcinoma
    • Systemic chemotherapy
    • +2 more
    • Guangzhou, Guangdong, China
      Cancer Center Sun Yat-sen University
    Feb 19, 2021

    Hepatocellular Carcinoma Trial in Guangzhou, Kaiping (HAIC of 130 mg/m² Oxaliplatin, and 5-fu, HAIC of 85 mg/m² Oxaliplatin, and

    Recruiting
    • Hepatocellular Carcinoma
    • HAIC of 130 mg/m² Oxaliplatin, and 5-fu
    • +2 more
    • Guangzhou, Guangdong, China
    • +2 more
    Jan 12, 2021

    HepatoCellular Carcinoma Trial in Guangzhou, Kaiping (2400 mg/m² 5-fu, 1200 mg/m² 5-fu)

    Recruiting
    • HepatoCellular Carcinoma
    • 2400 mg/m² 5-fu
    • 1200 mg/m² 5-fu
    • Guangzhou, Guangdong, China
    • +2 more
    Dec 9, 2020

    Hepatocellular Carcinoma Trial in Guangzhou, Kaiping (HAIC of FOLFOX, Sorafenib)

    Unknown status
    • Hepatocellular Carcinoma
    • Guangzhou, Guangdong, China
    • +2 more
    Dec 3, 2020